MexicoTaevas Global helps medical devices manufacturers navigate COFEPRIS registration requirements and enter the Mexico market with confidence, speed, and full regulatory compliance.
Our six interconnected pillars give medical devices companies a complete, actionable picture of the COFEPRIS registration landscape and Mexico market opportunity.
We map your device against Mexico's NOM standards and COFEPRIS classification framework to identify the precise registration pathway required. Our team evaluates whether your device qualifies as Class I, II, or III and determines which technical dossier requirements apply. This analysis prevents costly rework and sets a realistic timeline from day one.
Our four-step engagement moves from rapid scoping through deep regulatory research to a polished deliverable and live debrief, keeping your team informed and in control throughout.
We begin with a structured intake call to understand your device, its intended use, existing approvals in other markets, and your target timeline for Mexico market entry. Using this information we confirm the COFEPRIS device class and the applicable registration pathway. A scoping summary is shared within 48 hours so all stakeholders are aligned before work begins.
During scoping we collect your device description, predicate data, existing CE or FDA clearance documents, and any prior COFEPRIS correspondence. We cross-reference Mexico's NOM-137-SSA1 and related standards to confirm classification and identify whether the simplified pathway for devices already approved by recognized authorities applies. The output is a one-page scoping memo with pathway recommendation, estimated timeline, and a list of documents required for the dossier.
Mexico is the second largest medical devices market in Latin America, behind Brazil, and one of the top 15 globally by import volume. The country imports approximately 85 percent of the medical devices it consumes, making it a critical destination for foreign manufacturers. Proximity to the United States and established manufacturing corridors in states like Baja California and Chihuahua further strengthen Mexico's strategic position.
COFEPRIS, operating under the Secretaria de Salud, is the sole authority responsible for granting medical device marketing authorizations in Mexico. All devices sold commercially must hold a valid Registro Sanitario or be covered by an import permit, with Class III devices subject to the most rigorous review. Recent COFEPRIS modernization efforts have introduced electronic submission portals and streamlined pathways for devices already approved by recognized authorities such as the FDA and European Notified Bodies.
Mexico's public health system, anchored by IMSS, ISSSTE, and the IMSS-Bienestar program, represents the largest single buyer of medical devices in the country. Government procurement through the COMPRANET platform and consolidated purchasing agreements creates significant volume opportunities for registered manufacturers. Companies that achieve COFEPRIS registration and understand the tender process gain access to a procurement pipeline worth several billion pesos annually.
Mexico's medical devices sector is experiencing accelerating adoption of digital health tools, minimally invasive surgical equipment, and in-vitro diagnostics, driven by rising chronic disease prevalence and an expanding private hospital sector. The country's medical device manufacturing cluster, centered in the northern border states, also makes it a key export hub under the USMCA trade agreement. Manufacturers that register early in high-growth categories such as cardiovascular, orthopedic, and diagnostic imaging devices are positioned to capture disproportionate market share.
Each engagement produces a structured set of eight deliverables designed to take your medical device from pre-submission preparation through to a confident Mexico market entry.
A detailed document confirming your device's classification, the applicable registration pathway, required technical file sections, and an estimated COFEPRIS review timeline based on recent precedent.
A complete, COFEPRIS-formatted submission package including Spanish-language labeling, technical summaries, essential requirements checklist, and all supporting clinical and performance documentation.
A structured audit of your existing technical documentation against COFEPRIS requirements, with each gap flagged by severity and accompanied by a recommended remediation action and responsible party.
A cross-reference matrix mapping your device's technical specifications against all applicable Mexican Official Standards (NOMs) and identifying any areas requiring additional testing or documentation.
A milestone-based roadmap covering the period from submission through first commercial sale, including COFEPRIS review milestones, distributor onboarding steps, and public tender participation timelines.
A vetted shortlist of qualified Responsable Sanitario candidates and licensed importers in Mexico, with profiles covering regulatory experience, therapeutic area focus, and commercial reach.
A benchmarking brief covering registered competitors in your device category, their pricing strategies, public tender participation history, and positioning across Mexico's public and private hospital sectors.
A practical guide to Mexico's post-market obligations including vigilance reporting timelines, Registro Sanitario renewal requirements, and COFEPRIS inspection readiness recommendations.
You have CE marking or FDA clearance and are ready to expand into Latin America, but COFEPRIS requirements feel opaque and the local regulatory landscape is unfamiliar. Your team needs a clear pathway, a reliable local partner, and a submission package that will not generate endless deficiency letters. Time to market is critical because competitors are already filing.
Talk to a Taevas Global regulatory specialist today and get a clear picture of your COFEPRIS pathway, timeline, and what it takes to bring your medical device to market in Mexico.